MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Bruker Corporation Cash Conversion Cycle 2011-2026 | BRKR
Annual Cash Conversion Cycle Bruker Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 227 | 234 | 241 | 226 | 256 | 219 | 217 | 217 | 204 | 192 | 199 | 243 | 265 | 267 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 267 | 192 | 229 |
Quarterly Cash Conversion Cycle Bruker Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 236 | 269 | - | 255 | 246 | - | - | 243 | 247 | 243 | - | 119 | 123 | 244 | - | 232 | 232 | 237 | - | 253 | 286 | 275 | 55.1 | 220 | 229 | 231 | 58.9 | 221 | 228 | 229 | 54.9 | 219 | 227 | 231 | 47.3 | 211 | 220 | 212 | 44.8 | 194 | 195 | 245 | 52.7 | 209 | 201 | 236 | 50.8 | 255 | 247 | 290 | 51 | 267 | 275 | 286 | 54.3 | 262 | 276 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 290 | 44.8 | 202 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
113 | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
240 | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
245 | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 269.55 | 0.25 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.63 | 3.58 % | $ 173 M |  France |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 74.02 | -1.5 % | $ 110 B | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
240 | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
234 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
299 | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
180 | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
355 | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
-13.9 | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
314 | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
55.8 | $ 6.07 | 3.94 % | $ 144 M | USA |